TheraRadar
← Back
Data updated: Mar 29, 2026

LANNETT CO INC

Infectious DiseaseCardiovascularGastroenterology
Generics

LANNETT CO INC is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology.

1955
Since
102
Drugs
-
Trials
1288
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 28%
6 drugs
Cardiovascular 24%
5 drugs
Gastroenterology 24%
5 drugs
Neurology 14%
3 drugs
Metabolic 10%
2 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...